PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for June 29, 2005 Subscribe to this News Feed    
 

Corazon Announces July Topic for Online Executive Learning Series - July Webinar" to Focus on Specialty Design for Congestive Heart Failure Treatments

Corazon Consulting, a national leader in providing specialized consulting services to hospitals for development of cardiac and vascular programs, today announced that it will hold the second in its series of online Executive Learning forums on Wednesday, July 13th, 2005 at 1pm Eastern Time. The interactive, 90-minute session titled, Specialty Design: Developing Options for Congestive Heart Failure Treatment" will showcase how a variety of strategic design options can play a significant role in leveraging treatments for congestive heart failure.

(PRWEB) June 29, 2005 -- Corazon Consulting, a national leader in providing specialized consulting services to hospitals for development of cardiac and vascular programs, today announced that it will hold the second in its series of online Executive Learning forums on Wednesday, July 13th, 2005 at 1pm Eastern Time. The interactive, 90-minute session titled, Specialty Design: Developing Options for Congestive Heart Failure Treatment" will showcase how a variety of strategic design options can play a significant role in leveraging treatments for congestive heart failure. Web Seminar attendees can receive 1½ hours of pre-approved Category II continuing education credit, which can be applied toward advancement or recertification in the American College of Healthcare Executives.

Corazon Heart Expert and session co-presenter Ross Swanson stated, heart failure affects a large portion of the population...In fact, deaths from HF have increased 145% over the last 20 years and its become clear that cardiovascular programs need to be better equipped to effectively manage these patients. This presentation will outline the key components of a successful heart failure program, and explain some of the new techniques, devices, and technology that can help with early diagnosis and treatment..."

To register for the conference, call 412-364-8200 or visit Our Conferences" at www.corazon-consulting.com

About Corazon Consulting
Corazon Consulting is a recognized leader in strategic cardiovascular program development, assisting clients through the full spectrum of consulting services from feasibility study and business planning through implementation of services. The Corazon team of Heart Experts has assisted healthcare leaders and physicians in tertiary centers and community hospital settings toa bring specialized advice and progressive thinking in cardiovascular services to strategic planning, market assessments and financial analyses, clinical operations and new technology, Heart Centers and Heart Hospitals, physician-hospital partnering, best practice benchmarks, and staffing models and staff education for well-developed or newly established cardiovascular programs. Corazon pioneered the application of the Universal Bed in cardiovascular care delivery and brings firsthand experience with service line management as a progressive organizational means for healthcare providers. Corazon is a 2003 Ernst & Young Entrepreneur of the Year Company and one of the 2004 Pittsburgh 100" Companies. Call 412-364-8200 or visit www.corazon-consulting.com for more information.

# # #

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Cheryl Isen
ISEN AND COMPANY
425-222-0779
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.